Christopher B Prentiss - Net Worth and Insider Trading

Christopher B Prentiss Net Worth

The estimated net worth of Christopher B Prentiss is at least $1 Million dollars as of 2024-12-01. Christopher B Prentiss is the CFO of Adamas Pharmaceuticals Inc and owns about 145,017 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $1 Million. Details can be seen in Christopher B Prentiss's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher B Prentiss has not made any transactions after 2021-03-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Christopher B Prentiss

To

Christopher B Prentiss Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher B Prentiss owns 1 companies in total, including Adamas Pharmaceuticals Inc (ADMS) .

Click here to see the complete history of Christopher B Prentiss’s form 4 insider trades.

Insider Ownership Summary of Christopher B Prentiss

Ticker Comapny Transaction Date Type of Owner
ADMS Adamas Pharmaceuticals Inc 2021-03-22 Chief Financial Officer

Christopher B Prentiss Latest Holdings Summary

Christopher B Prentiss currently owns a total of 1 stock. Christopher B Prentiss owns 145,017 shares of Adamas Pharmaceuticals Inc (ADMS) as of March 22, 2021, with a value of $1 Million.

Latest Holdings of Christopher B Prentiss

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ADMS Adamas Pharmaceuticals Inc 2021-03-22 145,017 8.22 1,192,040

Holding Weightings of Christopher B Prentiss


Christopher B Prentiss Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher B Prentiss has made a total of 5 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Adamas Pharmaceuticals Inc is the sale of 2,422 shares on March 22, 2021, which brought Christopher B Prentiss around $13,273.

Insider Trading History of Christopher B Prentiss

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher B Prentiss Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher B Prentiss Ownership Network

Ownership Network List of Christopher B Prentiss

No Data

Ownership Network Relation of Christopher B Prentiss

Insider Network Chart

Christopher B Prentiss Owned Company Details

What does Adamas Pharmaceuticals Inc do?

Who are the key executives at Adamas Pharmaceuticals Inc?

Christopher B Prentiss is the Chief Financial Officer of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , director & 10 percent owner William W. Ericson , and Chief Executive Officer Neil F. Mcfarlane .

Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adamas Pharmaceuticals Inc Insider Transactions

No Available Data

Christopher B Prentiss Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher B Prentiss. You might contact Christopher B Prentiss via mailing address: 1900 Powell Street Suite 750 Emeryville Ca 94608.

Discussions on Christopher B Prentiss

No discussions yet.